INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,544 | -17.7% | 260 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16,464 | +16.9% | 260 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $14,079 | +20.9% | 260 | +18.2% | 0.00% | 0.0% |
| Q4 2022 | $11,642 | +16.4% | 220 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | +150.0% | 220 | -56.0% | 0.00% | +100.0% |
| Q3 2019 | $4,000 | 0.0% | 500 | +150.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | -33.3% | 200 | -42.9% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +200.0% | 350 | +321.7% | 0.00% | 0.0% |
| Q1 2018 | $2,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |